Mercalis

Roughly half of new launches that miss first-year forecasts do so largely attributed to market access challenges, including patients' out-of-pocket expenses and higher than anticipated costs on discounts and rebates. Learn how to increase speed to therapy and cost savings. Read more: https://bit.ly/3UIP0IS #patientservices #marketaccess

Patient access programs evolve over time. Discuss best practices to ensure that you are maintaining a robust patient access strategy throughout the entire lifecycle to showcase how to manage programs with decreasing budgets while increasing patient volume. Want to learn how, join Molly Stallings and Jack McGuire this week at #PatientSupport2024. https://bit.ly/3Csb8BR

Mercalis will be at the Copay, Reimbursement, and Access Congress next week. Join Terry Cato, Michael Harris and Blake Johnson as they present "Unleashing Compassionate Care: Integrated Patient Service Programs", where they will discuss how comprehensive patient support programs can significantly improve patient outcomes and operational efficiencies. https://bit.ly/4hKYhe3 #Mercalis #PatientAffordability #PatientSupport

Today, on World Diabetes Day, Mercalis reaffirms our commitment to supporting those impacted by diabetes. We stand with patients, healthcare professionals, and researchers working for better outcomes. Join us in raising awareness for advancement in diabetes care. https://bit.ly/4efSRFw #WorldDiabetesDay

We celebrate #WorldQualityWeek and embrace quality management principles to drive innovation and efficiency for patients. We are grateful for our superior quality management team that focuses on this each day for our clients. https://lnkd.in/gmAYcHrS

Today, we pause to thank and honor all who have served. Your courage, sacrifice, and dedication inspire us every day. At Mercalis, we are proud to support veterans in our workforce and beyond. We honor our Mercalis employees who served our great nation in this video. https://lnkd.in/eRKsrRdB

We have supported patients' treatment needs through our Non-Commercial Dispensing Pharmacy for six years. We are excited to announce we have expanded our facility to meet the industry demands and have incorporated technology to make us even more efficient. Our team joined together last week to celebrate this milestone: https://lnkd.in/e-PTekVf

We are honored to connect with Peter L. Saltonstall, outgoing CEO of National Organization for Rare Disorders (NORD) at their annual conference this week. Peter’s stewardship of NORD and his unwavering service to rare disease families is legendary.?NORD's commitment to the rare disease community will continue to grow with?Pamela Gavin, incoming CEO.?We are constantly humbled by the strength of the #RareDisease community.

Today, Mercalis announces the expansion of its state-of-the-art non-commercial dispensing pharmacy, allowing pharmaceutical manufacturers to provide patient assistance program services to uninsured or underinsured patients. In addition, Mercalis provides quick-start and bridge program services that offer a limited supply of free medication to patients initiating therapy. Read the press release to learn more: https://bit.ly/3YwB7R6

Join Heather Hays, an experienced Market Access and Patient Support Strategy professional at the CCO Summit to learn how to build a Market Access hiring plan and develop the department during her presentation. Also, visit the Mercalis booth to learn how we can partner with you throughout the commercialization lifecycle: https://bit.ly/3NRjaqp #lifesciences #CCO